Back to Search
Start Over
235MO Efficacy and safety of ribociclib (RIB) + nonsteroidal aromatase inhibitor (NSAI) in younger patients (pts) with HR+/HER2− early breast cancer (EBC) in NATALEE.
- Source :
-
Annals of Oncology . 2024 Supplement 2, Vol. 35, pS310-S311. 2p. - Publication Year :
- 2024
- Subjects :
- *AROMATASE inhibitors
*BREAST cancer
*SAFETY
Subjects
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 35
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 179691597
- Full Text :
- https://doi.org/10.1016/j.annonc.2024.08.178